Differential diagnosis between chronic pancreatitis and pancreatic cancer: Value of the detection of KRAS2 mutations in circulating DNA

British Journal of Cancer

Volumn 87, Issue 5, 2002, Pages 551-554

  Maire, Frederique ^a   Micard, S ^b   Hammel, P ^a   Voitot, H ^a   Levy P ^a   Cugnenc, P H ^c   Ruszniewski, P ^a   Puig, P Laurent ^b,c  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Chronic pancreatitis; Circulating DNA; KRAS2 mutations; Pancreatic adenocarcinoma

Indexed keywords

CARBOHYDRATE ANTIGEN; DNA;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENDER; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MALE; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ALLELES; CA-19-9 ANTIGEN; CHRONIC DISEASE; CODON; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENES, RAS; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SMOKING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037183673     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600475     Document Type: Article

References (41)

1. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
2. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
3. Pancreatography in chronic pancreatitis: International definitions
4. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: Impact of K-ras mutations
5. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
6. K-ras mutation and pancreatic adenocarcinoma
7. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
8. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis
9. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice
10. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma
11. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer
12. The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma
13. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy
14. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas
15. P53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis
16. Pancreatitis and the risk of pancreatic cancer
17. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53
18. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
19. The role of p21ras in pancreatic neoplasia and chronic pancreatitis
20. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme
21. Valeur diagnostique de l'antigène sérique Ca 19-9 au cours de la pancréatite chronique et de l'adénocarcinome pancréatique
22. EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass lesion: A prospective study
23. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates
24. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
25. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: Cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases
26. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer
27. Early detection of pancreatic cancer in patients with chronic pancreatitis: Diagnostic utility of a K-ras point mutation in the pancreatic juice
28. Comparison of CA19-9 with other tumor markers in the diagnosis of cancer of the pancreas
29. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification
30. Soluble normal and mutated DNA sequences from single-copy genes in human blood
31. Free DNA in serum and plasma from normal adults
32. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma
33. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma
34. Diagnostic value of K-ras mutations in serum of pancreatic cancer patients
35. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases
36. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma
37. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis
38. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma
39. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features
40. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: An unsatisfactory technique for clinical applications